Nationwide Fund Advisors’s Gyre Therapeutics GYRE Stock Holding History

Nationwide Fund Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12	Closed	-$2K	–	3210
2016 Q3	$2K	Hold	12	–	–	﹤0.01%	3213
2016 Q2	$2K	Hold	12	–	–	﹤0.01%	3247
2016 Q1	$2K	Hold	12	–	–	﹤0.01%	3226
2015 Q4	$4K	Hold	12	–	–	﹤0.01%	3194
2015 Q3	$6K	Hold	12	–	–	﹤0.01%	3219
2015 Q2	$26K	Hold	12	–	–	﹤0.01%	3146
2015 Q1	$28K	Hold	12	–	–	﹤0.01%	3161
2014 Q4	$24K	Hold	12	–	–	﹤0.01%	3082
2014 Q3	$24K	Hold	12	–	–	﹤0.01%	3153
2014 Q2	$42K	Sell	12 -27	-69%	-$88.1K	﹤0.01%	3108
2014 Q1	$144K	Sell	39 -1	-3%	-$3.7K	﹤0.01%	2628
2013 Q4	$129K	Hold	40	–	–	﹤0.01%	2870
2013 Q3	$168K	Buy	40 +1	+3%	+$4.02K	﹤0.01%	2745
2013 Q2	$130K	Buy	+39	New	+$148K	﹤0.01%	2687

Other funds holding GYRE

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

CCM

Colorado Capital Management Boulder, Colorado $293M AUM 22.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Nationwide Fund Advisors's GYRE Position: Q4 2016 in Review

Nationwide Fund Advisors sold out of Gyre Therapeutics (GYRE) in Q4 2016, closing a stake of 12 shares — an estimated $2K sold.

Nationwide Fund Advisors first reported a position in GYRE in Q2 2013 and held it in 14 quarters. The position peaked at $168K in Q3 2013. 27 funds tracked by Wall St. Rank hold GYRE as of Q4 2016.

Nationwide Fund Advisors reported no remaining Gyre Therapeutics position as of Q4 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 12 Gyre Therapeutics shares in Q4 2016, an estimated $2K.
Nationwide Fund Advisors first reported a position in Gyre Therapeutics in Q2 2013 and held it in 14 quarters.
Nationwide Fund Advisors's Gyre Therapeutics position peaked at $168K in Q3 2013.
27 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2016.

Based on Nationwide Fund Advisors's 13F filing for Q4 2016, filed 27 Jan 2017.